[1]Patent:US4680299,1987,A
[2]Patent:US4861783,1989,A
[1]Chemistry-AEuropeanJournal,2017,vol.23,p.13875-13878
[2]Cell,2016,vol.167,p.171-15,186
[3]Patent:WO2017/37022,2017,A1.Locationinpatent:Page/Pagecolumn54;55
[1]CurrentPatentAssignee:BROADINSTITUTE;MASSGENERALBRIGHAMINC;BAYERAG;HARVARDUNIVERSITY-WO2017/37022,2017,A1Locationinpatent:Page/Pagecolumn54;55
[2]Sykes,DavidB.;Kfoury,YoumnaS.;Mercier,FrançoisE.;Wawer,MathiasJ.;Law,JasonM.;Haynes,MarkK.;Lewis,TimothyA.;Schajnovitz,Amir;Jain,Esha;Lee,Dongjun;Meyer,Hanna;Pierce,KerryA.;Tolliday,NicolaJ.;Waller,Anna;Ferrara,StevenJ.;Eheim,AshleyL.;Stoeckigt,Detlef;Maxcy,KatrinaL.;Cobert,JulienM.;Bachand,Jacqueline;Szekely,BrianA.;Mukherjee,Siddhartha;Sklar,LarryA.;Kotz,JoanneD.;Clish,ClaryB.;Sadreyev,RuslanI.;Clemons,PaulA.;Janzer,Andreas;Schreiber,StuartL.;Scadden,DavidT.[Cell,2016,vol.167,#1,p.171-15,186]
[3]CurrentPatentAssignee:CLEARCREEKBIOINC-US2021/292280,2021,A1Locationinpatent:Paragraph0141-0144
[1]Madak,JosephT.;Cuthbertson,ChristineR.;Chen,Wenmin;Showalter,HollisD.;Neamati,Nouri[Chemistry-AEuropeanJournal,2017,vol.23,#56,p.13875-13878]
Title: On dihydroorotate dehydrogenases and their inhibitors and uses.
Journal: Journal of medicinal chemistry 20130425
Title: New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold.
Journal: European journal of medicinal chemistry 20120301
Title: Potent antiviral activity of brequinar against the emerging Cantagalo virus in cell culture.
Journal: International journal of antimicrobial agents 20111101
Title: Discovery of novel inhibitors for DHODH via virtual screening and X-ray crystallographic structures.
Journal: Bioorganic & medicinal chemistry letters 20100315
Title: The structures of human dihydroorotate dehydrogenase with and without inhibitor reveal conformational flexibility in the inhibitor and substrate binding sites.
Journal: Biochemistry 20080826
Title: Biochemical characterization of recombinant dihydroorotate dehydrogenase from the opportunistic pathogenic yeast Candida albicans.
Journal: The FEBS journal 20060701
Title: Brequinar derivatives and species-specific drug design for dihydroorotate dehydrogenase.
Journal: Bioorganic & medicinal chemistry letters 20060315
Title: Dual binding mode of a novel series of DHODH inhibitors.
Journal: Journal of medicinal chemistry 20060223
Title: Biphenyl-4-ylcarbamoyl thiophene carboxylic acids as potent DHODH inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20060115
Title: Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase.
Journal: Bioorganic & medicinal chemistry 20050315
Title: Inhibitor binding in a class 2 dihydroorotate dehydrogenase causes variations in the membrane-associated N-terminal domain.
Journal: Protein science : a publication of the Protein Society 20040401
Title: Malarial dihydroorotate dehydrogenase. Substrate and inhibitor specificity.
Journal: The Journal of biological chemistry 20021101
Title: In vitro and in Vivo inhibition of immunoglobulin secretion by the immunosuppressive compound HR325 is reversed by exogenous uridine.
Journal: Scandinavian journal of immunology 20020701
Title: Inhibition of cyclosporin-resistant B-cell antigen responses by pyrazoles: a tool for the identification of novel molecular mechanisms of B-cell activation.
Journal: Transplantation proceedings 20010501
Title: Multiple inhibitor analysis of the brequinar and leflunomide binding sites on human dihydroorotate dehydrogenase.
Journal: Biochemistry 20010220
Title: Anti-arthritic effects of KF20444, a new immunosuppressive compound inhibiting dihydroorotate dehydrogenase, on rat collagen-induced arthritis.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20010101
Title: Immunosuppressive drugs: the first 50 years and a glance forward.
Journal: Immunopharmacology 20000501
Title: Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives, brequinar sodium and polyporic acid.
Journal: Chemico-biological interactions 20000103
Title: Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives.
Journal: Biochemical pharmacology 19981101
Title: Structural and functional comparison of agents interfering with dihydroorotate, succinate and NADH oxidation of rat liver mitochondria.
Journal: Biochemical pharmacology 19981015
Title: 2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis.
Journal: Molecular pharmacology 19960701
Title: Phase I clinical and pharmacokinetic trial of Brequinar sodium (DuP 785; NSC 368390).
Journal: Cancer research 19890815
Title: The role of the tail in temperature regulation of the cotton rat, Sigmodon hispidus.
Journal: Comparative biochemistry and physiology. A, Comparative physiology 19751201
Title: Schnellrath LC, et al. Potent antiviral activity of brequinar against the emerging Cantagalo virus in cell culture. Int J Antimicrob Agents. 2011 Nov;38(5):435-41.
Title: Qing M, et al. Characterization of dengue virus resistance to brequinar in cell culture. Antimicrob Agents Chemother. 2010 Sep;54(9):3686-95.
Title: Xu X, et al. In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium. J Immunol. 1998 Jan 15;160(2):846-53.
Title: Zeping Zuo, et al. Bifunctional Naphtho,3-d,2,3triazole-4,9-dione Compounds Exhibit Antitumor Effects In Vitro and In Vivo by Inhibiting Dihydroorotate Dehydrogenase and Inducing Reactive Oxygen Species Production. J Med Chem. 2020 Jun 4.
Title: David C Schultz, et al. Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2. Nature. 2022 Feb 7.